The Bispecific Antibody Therapeutics Market is projected to grow at an annualized rate of ~16%, in the span of 2019 to 2030

The Large Volume Wearable Injectors Market is estimated to be worth around USD 600 million by 2030, predicts Roots Analysis

The Global Handheld Ultrasound Imaging Devices Market is projected to be over USD 1.1 billion by 2030, growing at a CAGR of 11%, claims Roots Analysis

The Gene Therapy Market is projected to grow at an annualized rate of 45%, till 2030

The “Companion Diagnostics Development Services Market, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of diagnostic development services over the next decade.

Over 100 companies across the globe claim to provide contract fill / finish services for prefilled syringes; close to 50%

Presently, close to 140 companies claim to be actively engaged in offering patient recruitment / retention services to the pharmaceutical and medical devices industries, employing a variety of outreach methods and solutions, claims Roots Analysis

The “Ophthalmic Drugs Contract Manufacturing Market, 2020-2030” report features an extensive study of the contract services market for ophthalmic APIs and drug FDFs

More than 80 companies currently claim to offer manufacturing related services, at different scales of operations, for a variety of oligonucleotide-based products, claims Roots Analysis

Over 180 companies from different regions across the globe presently claim to provide services for the development of companion diagnostic tests, claims Roots Analysis

The Prefilled Syringe Fill / Finish Services Market is projected to grow at an annualized rate of over 10%, till 2030

More than 240 companies across the globe claim to have the required capabilities to offer variety of services on a contract basis, working at different scales of operation

The Oligonucleotide Synthesis, Modification and Purification Services Market is projected to grow at an annualized rate of ~10%, till 2030

The Companion Diagnostics Development Services Market is projected to grow at an annualized rate of ~5%, till 2030

The Prefilled Syringe Fill / Finish Services Market is estimated to is estimated to reach close to USD 3 Billion by 2030, predicts Roots Analysis

The Patient Recruitment and Retention Services Market is estimated to be worth USD 5.3 billion in 2030, predicts Roots Analysis

The Ophthalmic Drugs Contract Manufacturing Market is projected to grow at an annualized rate of ~8%, till 2030

The Oligonucleotide Synthesis, Modification And Purification Services Market is estimated to be worth USD 5.8 billion in 2030, predicts Roots Analysis

The Companion Diagnostics Development Services Market is estimated to be worth over USD 800 million in 2030, predicts Roots Analysis

The “In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules (Antibodies, Proteins, Peptides, Nucleic Acid, Gene Therapy and Vectors), 2020-2030

The “HPAPI and Cytotoxic Drugs Manufacturing Market (3rd Edition), 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the manufacturing of HPAPIs and cytotoxic drugs over the next decade.

The “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of this approach over the next decade.

Presently, over 150 neoantigen targeted therapies are being evaluated for advanced cancer indications and are designed for delivery via different routes of administration

Over 90 firms are actively involved in providing in silico services for drug discovery of different types of biologics; of these, over 30 players claim to have the capabilities to offer services for all steps of discovery

Close to 120 companies across the globe claim to possess the required expertise and infrastructure to offer contract manufacturing services for HPAPIs and cytotoxic drugs, claims Roots Analysis

Over 85 firms are involved in providing fragment-based drug discovery-related services; of these, around 40 players claim to offer both libraries and technologies

The Neoantigen Targeted Therapies Market is projected to grow at an annualized rate of 57%, till 2030

The “Oligonucleotide Synthesis, Modification and Purification Services Market, Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030” report features a detailed study of the current scenario and future

The process of drug development, beginning from the discovery of a pharmacological lead to its commercial launch, is estimated to take around 10-15 years, involving capital investments in the range of USD 4-10 billion.

Human Microbiome Market: Focus on Therapeutics (including gut-brain axis targeting drugs), Diagnostics and Fecal Microbiota Therapies (FMTs) (3rd Edition), 2019-2030’ report features an extensive study of the current market

The “Ophthalmic Drugs Contract Manufacturing Market, 2020-2030” report features an extensive study of the contract services market for ophthalmic APIs and drug FDFs) – Roots Analysis

More than 80 companies currently claim to offer manufacturing related services, at different scales of operations, for a variety of oligonucleotide-based products, claims Roots Analysis

Presently, over 150 Neoantigen Targeted Therapies are being evaluated for advanced cancer indications and are designed for delivery via different routes of administration

Over 90 firms are actively involved in providing in silico services for drug discovery of different types of biologics; of these, over 30 players claim to have the capabilities to offer services for all steps of discovery

More than 240 companies across the globe claim to have the required capabilities to offer variety of services on a contract basis, working at different scales of operation, for a wide range of ophthalmic APIs and drug FDFs, claims Roots Analysis

The Oligonucleotide Synthesis, Modification and Purification Services Market is projected to grow at an annualized rate of ~10%, till 2030

The Neoantigen Targeted Therapies Market is projected to grow at an annualized rate of 57%, till 2030

In Silico Drug Discovery Services Market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysis

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, growing at an annualized rate of over 40%, claims Roots Analysis

The Ophthalmic Drugs Contract Manufacturing Market is projected to grow at an annualized rate of ~8%, till 2030

The Oligonucleotide Synthesis, Modification and Purification Services Market is estimated to be worth USD 5.8 billion in 2030, predicts Roots Analysis

The Neoantigen Targeted Therapies Market is estimated to be worth USD 3 Billion in 2030, predicts Roots Analysis

In Silico Drug Discovery Services Market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysis

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, growing at an annualized rate of over 40%, claims Roots Analysis

More than 100 industry players and over 60 non-industry players currently claim to manufacture different types of cell therapies, either for in-house requirements or on contract basis

The “Biopharmaceutical Contract Manufacturing Market (3rd edition), 2019 – 2030” report features an extensive study on the contract service providers within the biopharmaceutical industry.

The “Antibody Contract Manufacturing Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of antibodies.

More than 150 industry players across the world are presently engaged in evaluating the potential of nearly 300 next generation immune checkpoint modulators for the treatment of multiple disease indications, claims Roots Analysis

More than 100 industry players and over 60 non-industry players currently claim to manufacture different types of cell therapies, either for in-house requirements or on contract basis

Several companies worldwide claim to possess the required expertise and infrastructure to offer contract manufacturing services for a variety of antibody-based products